Pharmadrug Inc.
PHRX
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.40K | 72.50K | 10.40K | 5.40K | 23.60K |
| Depreciation & Amortization | 9.00K | 9.00K | 9.10K | 9.10K | 8.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.40K | 81.50K | 19.50K | 14.50K | 32.40K |
| Operating Income | -31.40K | -81.50K | -19.50K | -14.50K | -32.40K |
| Income Before Tax | -141.50K | -102.90K | -63.30K | -61.30K | -81.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -141.50K | -102.90K | -63.30K | -61.30K | -81.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 7.20K | 7.20K | 7.20K | 8.80K | 11.80K |
| Net Income | -134.30K | -95.70K | -56.00K | -52.50K | -69.80K |
| EBIT | -31.40K | -81.50K | -19.50K | -14.50K | -32.40K |
| EBITDA | -22.40K | -72.50K | -10.40K | -5.40K | -23.60K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 134.21M | 108.24M | 108.23M | 108.23M | 107.77M |
| Average Diluted Shares Outstanding | 134.21M | 108.24M | 108.23M | 108.23M | 107.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |